A genomic view of the complexity of mammalian proteolytic systems
- PMID: 15787599
- DOI: 10.1042/BST0330331
A genomic view of the complexity of mammalian proteolytic systems
Abstract
Proteolytic enzymes play an essential role in different physiological processes, including development, reproduction and host defence, as well as in numerous pathologies, like inflammatory diseases, neurological disorders or cancer. The completion of the human genome sequence allowed us to determine that more than 2% of all human genes are proteases or protease inhibitors, reflecting the importance of proteolysis in human biology. To understand better the complexity of proteases in human and other model organisms, we have used the available genome sequences of different mammalian organisms, including mouse, rat and chimpanzee, to identify and compare their degradomes, the complete set of protease genes in these species. Surprisingly, the rodent protease complement is more complex when compared with that of primates, mainly due to the expansion of protease families implicated in reproduction and host defence. Similarly, most differences between human and chimpanzee proteases are found in genes implicated in the immune system, which might explain some of the differences between both organisms. We have also found several genes implicated in reproduction, nutrition and the immune system, which are functional in rat, mouse or chimpanzee, but have been inactivated by mutations in the human lineage. These findings suggest that pseudogenization of specific protease genes has been a mechanism contributing to the evolution of the human genome. Finally, we found that proteases implicated in human hereditary diseases, and especially in neurodegenerative disorders, are highly conserved among mammals.
Similar articles
-
Comparative genomic analysis of human and chimpanzee proteases.Genomics. 2005 Dec;86(6):638-47. doi: 10.1016/j.ygeno.2005.07.009. Epub 2005 Sep 12. Genomics. 2005. PMID: 16162398
-
Proteolytic systems: constructing degradomes.Methods Mol Biol. 2009;539:33-47. doi: 10.1007/978-1-60327-003-8_2. Methods Mol Biol. 2009. PMID: 19377972 Review.
-
Bioinformatics of proteases in the MEROPS database.Curr Opin Drug Discov Devel. 2004 May;7(3):334-41. Curr Opin Drug Discov Devel. 2004. PMID: 15216937 Review.
-
Comparative genomics of mycobacterial proteases.Microb Pathog. 2007 Nov-Dec;43(5-6):173-8. doi: 10.1016/j.micpath.2007.05.010. Epub 2007 Jun 2. Microb Pathog. 2007. PMID: 17611072 Review.
-
Protease proteomics: revealing protease in vivo functions using systems biology approaches.Mol Aspects Med. 2008 Oct;29(5):339-58. doi: 10.1016/j.mam.2008.04.003. Epub 2008 May 1. Mol Aspects Med. 2008. PMID: 18571712 Review.
Cited by
-
Allostery in trypsin-like proteases suggests new therapeutic strategies.Trends Biotechnol. 2011 Nov;29(11):577-85. doi: 10.1016/j.tibtech.2011.06.001. Epub 2011 Jul 2. Trends Biotechnol. 2011. PMID: 21726912 Free PMC article. Review.
-
A bioavailable cathepsin S nitrile inhibitor abrogates tumor development.Mol Cancer. 2016 Apr 21;15:29. doi: 10.1186/s12943-016-0513-7. Mol Cancer. 2016. PMID: 27097645 Free PMC article.
-
Nanoclay/Polymer-Based Hydrogels and Enzyme-Loaded Nanostructures for Wound Healing Applications.Gels. 2021 May 14;7(2):59. doi: 10.3390/gels7020059. Gels. 2021. PMID: 34068868 Free PMC article. Review.
-
Characterizing Protease Specificity: How Many Substrates Do We Need?PLoS One. 2015 Nov 11;10(11):e0142658. doi: 10.1371/journal.pone.0142658. eCollection 2015. PLoS One. 2015. PMID: 26559682 Free PMC article.
-
Catalytic Site pKa Values of Aspartic, Cysteine, and Serine Proteases: Constant pH MD Simulations.J Chem Inf Model. 2020 Jun 22;60(6):3030-3042. doi: 10.1021/acs.jcim.0c00190. Epub 2020 May 29. J Chem Inf Model. 2020. PMID: 32348143 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources